Finance

Lists
Why is INDGN up 2,12%?
Dive Deeper
INDGN:NSE
Indegene Ltd
₹593,00
+2,12%
(+12,30) 1D
14 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for INDGN...
Open
₹579,90
High
₹599,75
Low
₹574,30
Mkt. cap
142,90 mjd
Avg. vol.
605,03 k
Volume
289,64 k
Dividend
0,38%
Quarterly dividend
₹0,56
Ex-dividend date
31 Jul. 2026
P/E ratio
35,68
52-wk high
₹627,00
52-wk low
₹414,00
EPS
₹16,62
No. of employees
5 k
Open
₹579,90
High
₹599,75
Low
₹574,30
Mkt. cap
142,90 mjd
Avg. vol.
605,03 k
Volume
289,64 k
Dividend
0,38%
Quarterly dividend
₹0,56
Ex-dividend date
31 Jul. 2026
P/E ratio
35,68
52-wk high
₹627,00
52-wk low
₹414,00
EPS
₹16,62
No. of employees
5 k
News stories
From web sources and news partners
Profile
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. Wikipedia
About Indegene Ltd
CEOManish Gupta
Employees4,69 k
Founded1998
Headquarters-
SectorHealth care
Websiteindegene.com
Last report
31 Jul. 2026
Fiscal period
Q1 2027
₹4,81 / ₹4,62
+4,00%beat
Revenue / Est. (INR)
10,63 mjd / 10,56 mjd
+0,63%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
8,04 mjd
9,42 mjd
10,03 mjd
10,63 mjd
Cost of goods sold
-
-
778,00 m
-
Cost of revenue
-
-
778,00 m
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,16 mjd
5,68 mjd
6,39 mjd
6,59 mjd
Operating expense
6,87 mjd
8,22 mjd
7,99 mjd
9,33 mjd
Total operating expenses
6,87 mjd
8,22 mjd
8,77 mjd
9,33 mjd
Operating income
1,17 mjd
1,20 mjd
1,26 mjd
1,30 mjd
Other non operating income
197,00 m
194,00 m
-620,00 m
290,00 m
EBT including unusual items
1,33 mjd
1,35 mjd
1,05 mjd
1,53 mjd
EBT excluding unusual items
1,33 mjd
1,35 mjd
944,00 m
1,53 mjd
Income tax expense
310,00 m
318,00 m
254,00 m
365,00 m
Effective tax rate
23,29%
23,61%
24,17%
23,90%
Other operating expenses
1,48 mjd
2,15 mjd
1,18 mjd
2,30 mjd
Net income
1,02 mjd
1,03 mjd
797,00 m
1,16 mjd
Net profit margin
12,70%
10,92%
7,94%
10,93%
Earnings per share
4,23
4,26
3,94
4,81
Interest and investment income
-
-
363,00 m
-
Interest expense
-38,00 m
-46,00 m
-39,00 m
-64,00 m
Net interest expenses
-38,00 m
-46,00 m
324,00 m
-64,00 m
Depreciation and amortization charges
234,00 m
396,00 m
418,00 m
441,00 m
EBITDA
1,40 mjd
1,33 mjd
1,49 mjd
1,53 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme